Lv C, Chen J, Wang Y, Lin Y
Front Oncol. 2025; 15:1453786.
PMID: 40034598
PMC: 11872884.
DOI: 10.3389/fonc.2025.1453786.
Guan C, Gao J, Zou X, Shi W, Hao Y, Ge Y
Adv Sci (Weinh). 2025; 12(10):e2409173.
PMID: 39836545
PMC: 11904980.
DOI: 10.1002/advs.202409173.
Zabeti Touchaei A, Vahidi S
J Transl Med. 2024; 22(1):1131.
PMID: 39707465
PMC: 11662517.
DOI: 10.1186/s12967-024-05963-5.
Ghidotti P, Petraroia I, Fortunato O, Pontis F
Extracell Vesicles Circ Nucl Acids. 2024; 4(1):59-71.
PMID: 39698297
PMC: 11648522.
DOI: 10.20517/evcna.2022.42.
Chen S, Li L, Xu W, Xie N, Xu H, Zhou Y
Front Mol Biosci. 2024; 11:1513919.
PMID: 39698112
PMC: 11652353.
DOI: 10.3389/fmolb.2024.1513919.
Interferon Gamma Receptor 2 Collaborates With Circular RNA/MicroRNA to Modulate Programmed Cell Death-Ligand 1 Levels in Nasopharyngeal Carcinoma.
Guan G, Fu Z, Zhang D, Guo Y, Guo F, Wan Y
World J Oncol. 2024; 15(6):929-941.
PMID: 39697423
PMC: 11650609.
DOI: 10.14740/wjon1994.
Molecular Biology of Cancer-Interplay of Malignant Cells with Emerging Therapies.
Boussios S, Sheriff M, Ovsepian S
Int J Mol Sci. 2024; 25(23).
PMID: 39684799
PMC: 11642048.
DOI: 10.3390/ijms252313090.
Circular RNAs in Viral Infection and Antiviral Treatment.
Yin X, Li H, Zhou Y
Cells. 2024; 13(23.
PMID: 39682781
PMC: 11640649.
DOI: 10.3390/cells13232033.
The mechanism of PDE7B inhibiting the development of hepatocellular carcinoma through oxidative stress.
Luo Y, Gao H, Zhao J, Chen L, Shao J, Ju L
Front Immunol. 2024; 15:1469740.
PMID: 39640266
PMC: 11617559.
DOI: 10.3389/fimmu.2024.1469740.
Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies.
Ma Y, Zhang X, Liu C, Zhao Y
MedComm (2020). 2024; 5(12):e70009.
PMID: 39611045
PMC: 11604295.
DOI: 10.1002/mco2.70009.
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities.
Li J, Zhou W, Wang H, Huang M, Deng H
MedComm (2020). 2024; 5(12):e70019.
PMID: 39584047
PMC: 11586091.
DOI: 10.1002/mco2.70019.
m6A-modified exosome-derived circHIF1α binding to KH domain of IGF2BP3 mediates DNA damage and arrests G1/S transition phase to resists bacterial infection in bacteremia.
Yu J, Gao Y, Liu F, Zhang Y, Li J, Ding L
J Nanobiotechnology. 2024; 22(1):654.
PMID: 39443946
PMC: 11515445.
DOI: 10.1186/s12951-024-02932-4.
The role of kinesin superfamily proteins in hepatocellular carcinoma.
Ghnim Z, Mahdi M, Ballal S, Chahar M, Verma R, Ali Al-Nuaimi A
Med Oncol. 2024; 41(11):271.
PMID: 39400594
DOI: 10.1007/s12032-024-02497-0.
Circular RNA circEZH2 Promotes Lung Adenocarcinoma Progression by Regulating microRNA-495-3p/Tumor Protein D52 Axis and Activating Nuclear Factor-Kappa B Pathway.
Chen L, Xiang T, Xing J, Lu X, Wei S, Wang H
Int J Gen Med. 2024; 17:4419-4433.
PMID: 39359616
PMC: 11446202.
DOI: 10.2147/IJGM.S473202.
Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1.
Zang X, He X, Xiao C, Lin Q, Wang M, Liu C
Mol Cancer. 2024; 23(1):207.
PMID: 39334380
PMC: 11438063.
DOI: 10.1186/s12943-024-02124-6.
Deciphering Dormant Cells of Lung Adenocarcinoma: Prognostic Insights from O-glycosylation-Related Tumor Dormancy Genes Using Machine Learning.
Dong C, Liu Y, Chong S, Zeng J, Bian Z, Chen X
Int J Mol Sci. 2024; 25(17).
PMID: 39273449
PMC: 11395112.
DOI: 10.3390/ijms25179502.
Circular RNAs in human diseases.
Wang Y, Zhang J, Yang Y, Liu Z, Sun S, Li R
MedComm (2020). 2024; 5(9):e699.
PMID: 39239069
PMC: 11374765.
DOI: 10.1002/mco2.699.
Circular RNAs in lung cancer: implications for preventing therapeutic resistance.
Liu W, Sun Y, Huo Y, Zhang L, Zhang N, Yang M
EBioMedicine. 2024; 107:105309.
PMID: 39191172
PMC: 11445705.
DOI: 10.1016/j.ebiom.2024.105309.
The multifaceted roles of circular RNAs in cancer hallmarks: From mechanisms to clinical implications.
Kundu I, Varshney S, Karnati S, Naidu S
Mol Ther Nucleic Acids. 2024; 35(3):102286.
PMID: 39188305
PMC: 11345389.
DOI: 10.1016/j.omtn.2024.102286.
Circular RNAs in tumor immunity and immunotherapy.
Zhang W, Xu C, Yang Z, Zhou J, Peng W, Zhang X
Mol Cancer. 2024; 23(1):171.
PMID: 39169354
PMC: 11337656.
DOI: 10.1186/s12943-024-02082-z.